Physician profile
Emma Giuliani
NPI 1770922064
$1,341.61
in general payments reported to CMS, 2019-2025
8 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $296 · 2023: $386 · 2024: $329 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.99 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $430.35 | 2022-2024 | Menopur |
| Hologic Sales and Service, LLC | $383.80 | 2021-2025 | Myosure Tissue Removal Device, Omni Hysteroscope, Fluent Fluid Management System |
| Sumitomo Pharma America, INC. | $264.59 | 2023-2025 | Myfembree |
| Abbvie INC. | $102.54 | 2022-2023 | |
| Emd Serono, INC. | $49.98 | 2022 | |
| Coopersurgical, INC. | $44.30 | 2023-2024 | Stripper |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Organon LLC | $22.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Giuliani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.